We are excited to announce a significant milestone for KiraGen Bio and our mission towards inclusive innovation: Aaron Edwards, our Co-Founder and CEO, has been selected as a 2024 Termeer Fellow. This achievement is not only a testament to Aaron's visionary leadership in developing advanced CAR-T cell therapies for solid tumors but also reflects our shared commitment to fostering diversity and inclusivity at the leadership level in biotech. The Termeer Foundation champions values-driven leadership, emphasizing the importance of broadening representation within the biopharmaceutical industry—particularly for women, people with disabilities, LGBTQIA+ individuals, and Black, Brown, and Indigenous People of Color. Aaron's selection aligns with KiraGen's core values of innovation, inclusivity, and transformational change in healthcare. Through this fellowship, Aaron will gain access to an invaluable network of mentoring, professional development, and peer-to-peer sharing opportunities, further empowering KiraGen to break down silos and lead the way in developing life-changing cancer treatments.
Discover more about the Termeer Fellowship and its commitment to inclusivity here.
